FINS vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
FINS presents a classic value-trap profile with a stable Piotroski F-Score of 4/9 and a significant disconnect between its Graham Number ($27.46) and current market price ($12.79). While the asset is fundamentally undervalued with a Price/Book of 0.64 and a highly attractive 10.64% dividend yield, the technical trend is completely bearish (0/100). The lack of growth data and a very low current ratio (0.20) offset the valuation strengths, suggesting a stagnant price action despite the deep discount to defensive fair value.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
FINS vs JPM: Head-to-Head Comparison
This page compares Angel Oak Financial Strategies Income Term Trust (FINS) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.